228 related articles for article (PubMed ID: 31060578)
21. Onset and organ specificity of Tk2 deficiency depends on Tk1 down-regulation and transcriptional compensation.
Dorado B; Area E; Akman HO; Hirano M
Hum Mol Genet; 2011 Jan; 20(1):155-64. PubMed ID: 20940150
[TBL] [Abstract][Full Text] [Related]
22. Reversion of mtDNA depletion in a patient with TK2 deficiency.
Vilà MR; Segovia-Silvestre T; Gámez J; Marina A; Naini AB; Meseguer A; Lombès A; Bonilla E; DiMauro S; Hirano M; Andreu AL
Neurology; 2003 Apr; 60(7):1203-5. PubMed ID: 12682338
[TBL] [Abstract][Full Text] [Related]
23. Myopathic mtDNA Depletion Syndrome Due to Mutation in TK2 Gene.
Martín-Hernández E; García-Silva MT; Quijada-Fraile P; Rodríguez-García ME; Rivera H; Hernández-Laín A; Coca-Robinot D; Fernández-Toral J; Arenas J; Martín MA; Martínez-Azorín F
Pediatr Dev Pathol; 2017; 20(5):416-420. PubMed ID: 28812460
[TBL] [Abstract][Full Text] [Related]
24. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
Lesko N; Naess K; Wibom R; Solaroli N; Nennesmo I; von Döbeln U; Karlsson A; Larsson NG
Neuromuscul Disord; 2010 Mar; 20(3):198-203. PubMed ID: 20083405
[TBL] [Abstract][Full Text] [Related]
25. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy.
Saada A; Shaag A; Mandel H; Nevo Y; Eriksson S; Elpeleg O
Nat Genet; 2001 Nov; 29(3):342-4. PubMed ID: 11687801
[TBL] [Abstract][Full Text] [Related]
26. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
[TBL] [Abstract][Full Text] [Related]
27. Gene expression deregulation in postnatal skeletal muscle of TK2 deficient mice reveals a lower pool of proliferating myogenic progenitor cells.
Paredes JA; Zhou X; Höglund S; Karlsson A
PLoS One; 2013; 8(1):e53698. PubMed ID: 23341978
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial DNA copy number threshold in mtDNA depletion myopathy.
Durham SE; Bonilla E; Samuels DC; DiMauro S; Chinnery PF
Neurology; 2005 Aug; 65(3):453-5. PubMed ID: 16087914
[TBL] [Abstract][Full Text] [Related]
29. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy.
Blakely E; He L; Gardner JL; Hudson G; Walter J; Hughes I; Turnbull DM; Taylor RW
Neuromuscul Disord; 2008 Jul; 18(7):557-60. PubMed ID: 18508266
[TBL] [Abstract][Full Text] [Related]
30. Mild myopathic phenotype in a patient with homozygous c.416C > T mutation in
Papadimas GK; Vargiami E; Dragoumi P; Van Coster R; Smet J; Seneca S; Papadopoulos C; Kararizou E; Zafeiriou D
Acta Myol; 2020 Jun; 39(2):94-97. PubMed ID: 32904881
[TBL] [Abstract][Full Text] [Related]
31. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
[TBL] [Abstract][Full Text] [Related]
32. Thymidine kinase 2 enzyme kinetics elucidate the mechanism of thymidine-induced mitochondrial DNA depletion.
Sun R; Wang L
Biochemistry; 2014 Oct; 53(39):6142-50. PubMed ID: 25215937
[TBL] [Abstract][Full Text] [Related]
33. Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.
Blázquez-Bermejo C; Molina-Granada D; Vila-Julià F; Jiménez-Heis D; Zhou X; Torres-Torronteras J; Karlsson A; Martí R; Cámara Y
EBioMedicine; 2019 Aug; 46():342-355. PubMed ID: 31351931
[TBL] [Abstract][Full Text] [Related]
34. mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency.
Saada A; Shaag A; Elpeleg O
Mol Genet Metab; 2003 May; 79(1):1-5. PubMed ID: 12765840
[TBL] [Abstract][Full Text] [Related]
35. Clinical and molecular spectrum of thymidine kinase 2-related mtDNA maintenance defect.
Wang J; Kim E; Dai H; Stefans V; Vogel H; Al Jasmi F; Schrier Vergano SA; Castro D; Bernes S; Bhambhani V; Long C; El-Hattab AW; Wong LJ
Mol Genet Metab; 2018 Jun; 124(2):124-130. PubMed ID: 29735374
[TBL] [Abstract][Full Text] [Related]
36. Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions.
Tyynismaa H; Sun R; Ahola-Erkkilä S; Almusa H; Pöyhönen R; Korpela M; Honkaniemi J; Isohanni P; Paetau A; Wang L; Suomalainen A
Hum Mol Genet; 2012 Jan; 21(1):66-75. PubMed ID: 21937588
[TBL] [Abstract][Full Text] [Related]
37. Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions.
Alston CL; Schaefer AM; Raman P; Solaroli N; Krishnan KJ; Blakely EL; He L; Craig K; Roberts M; Vyas A; Nixon J; Horvath R; Turnbull DM; Karlsson A; Gorman GS; Taylor RW
Neurology; 2013 Dec; 81(23):2051-3. PubMed ID: 24198295
[TBL] [Abstract][Full Text] [Related]
38. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene.
Oskoui M; Davidzon G; Pascual J; Erazo R; Gurgel-Giannetti J; Krishna S; Bonilla E; De Vivo DC; Shanske S; DiMauro S
Arch Neurol; 2006 Aug; 63(8):1122-6. PubMed ID: 16908738
[TBL] [Abstract][Full Text] [Related]
39. Pathological Features in Paediatric Patients with TK2 Deficiency.
Jou C; Nascimento A; Codina A; Montoya J; López-Gallardo E; Emperador S; Ruiz-Pesini E; Montero R; Natera-de Benito D; Ortez CI; Marquez J; Zelaya MV; Gutierrez-Mata A; Badosa C; Carrera-García L; Expósito-Escudero J; Roldán M; Camara Y; Marti R; Ferrer I; Jimenez-Mallebrera C; Artuch R
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232299
[TBL] [Abstract][Full Text] [Related]
40. Novel mutations in the thymidine kinase 2 gene (TK2) associated with fatal mitochondrial myopathy and mitochondrial DNA depletion.
Tulinius M; Moslemi AR; Darin N; Holme E; Oldfors A
Neuromuscul Disord; 2005 Jun; 15(6):412-5. PubMed ID: 15907288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
